Skip to main content
Top

Cancer Immunology, Immunotherapy

Issue 1/2023

Content (22 Articles)

Open Access Glioblastoma Original Article

Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma

Lucia Longhitano, Nunzio Vicario, Stefano Forte, Cesarina Giallongo, Giuseppe Broggi, Rosario Caltabiano, Giuseppe Maria Vincenzo Barbagallo, Roberto Altieri, Giuseppina Raciti, Michelino Di Rosa, Massimo Caruso, Rosalba Parenti, Arcangelo Liso, Federica Busi, Marco Lolicato, Maria Caterina Mione, Giovanni Li Volti, Daniele Tibullo

Open Access Glioblastoma Correction

Correction to: Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma

Lucia Longhitano, Nunzio Vicario, Stefano Forte, Cesarina Giallongo, Giuseppe Broggi, Rosario Caltabiano, Giuseppe Maria Vincenzo Barbagallo, Roberto Altieri, Giuseppina Raciti, Michelino Di Rosa, Massimo Caruso, Rosalba Parenti, Arcangelo Liso, Federica Busi, Marco Lolicato, Maria Caterina Mione, Giovanni Li Volti, Daniele Tibullo

Open Access Checkpoint Inhibitors Original Article

Dynamic peripheral blood immune cell markers for predicting the response of patients with metastatic cancer to immune checkpoint inhibitors

Chen Wei, Mengyu Wang, Quanli Gao, Shasha Yuan, Wenying Deng, Liangyu Bie, Yijie Ma, Chi Zhang, Shuyi Li, Suxia Luo, Ning Li

Open Access Fluorescence in Situ Hybridization Original Article

An oral WT1 protein vaccine composed of WT1-anchored, genetically engineered Bifidobacterium longum allows for intestinal immunity in mice with acute myeloid leukemia

Natsuki Nakagawa, Yoshiko Hashii, Hisako Kayama, Ryu Okumura, Hiroko Nakajima, Hikaru Minagawa, Soyoko Morimoto, Fumihiro Fujiki, Jun Nakata, Toshiro Shirakawa, Takane Katayama, Kiyoshi Takeda, Akihiro Tsuboi, Keiichi Ozono

Open Access Acidosis Original Article

Acidosis significantly alters immune checkpoint expression profiles of T cells from oesophageal adenocarcinoma patients

Maria Davern, Noel E. Donlon, Fiona O’Connell, Caoimhe Gaughan, Cillian O’Donovan, Mohammed Habash, Andrew D. Sheppard, Michael MacLean, Margaret R. Dunne, Jenny Moore, Hugo Temperley, Melissa J. Conroy, Christine Butler, Anshul Bhardwaj, Narayanasamy Ravi, Claire L. Donohoe, John V. Reynolds, Joanne Lysaght

Open Access Cervical Cancer Original Article

Myeloid-derived suppressor cells cross-talk with B10 cells by BAFF/BAFF-R pathway to promote immunosuppression in cervical cancer

Ding Jianyi, Gan Haili, Yin Bo, Yang Meiqin, Huang Baoyou, Hu Haoran, Li Fang, Zheng Qingliang, Han Lingfei

Open Access Cervical Cancer Correction

Correction to: Myeloid-derived suppressor cells cross-talk with B10 cells by BAFF/BAFF-R pathway to promote immunosuppression in cervical cancer

Ding Jianyi, Gan Haili, Yin Bo, Yang Meiqin, Huang Baoyou, Hu Haoran, Li Fang, Zheng Qingliang, Han Lingfei

NSCLC Original Article

First-line single-agent pembrolizumab for PD-L1-positive (tumor proportion score ≥ 50%) advanced non-small cell lung cancer in the real world: impact in brain metastasis: a national French multicentric cohort (ESCKEYP GFPC study)

Renaud Descourt, Laurent Greillier, Maurice Perol, Charles Ricordel, Jean-Bernard Auliac, Lionel Falchero, Radj Gervais, Rémi Veillon, Sabine Vieillot, Florian Guisier, Marie Marcq, Grégoire Justeau, Laurence Bigay-Game, Marie Bernardi, Pierre Fournel, Hélène Doubre, Julian Pinsolle, Karim Amrane, Christos Chouaïd, Chantal Decroisette

NSCLC Original Article

Circ-HSP90A expedites cell growth, stemness, and immune evasion in non-small cell lung cancer by regulating STAT3 signaling and PD-1/PD-L1 checkpoint

Jie Lei, Jianfei Zhu, Bengang Hui, Chenghui Jia, Xiaolong Yan, Tao Jiang, Xiaoping Wang

Original Article

Selective delipidation of Mycobacterium bovis BCG retains antitumor efficacy against non-muscle invasive bladder cancer

Niannian Ji, Meijun Long, Andreu Garcia-Vilanova, Russell Ault, Juan I. Moliva, Kizil A. Yusoof, Neelam Mukherjee, Tyler J. Curiel, Hong Dixon, Jordi B. Torrelles, Robert S. Svatek

Open Access Cystectomy Original Article

Intratumoral T cell depletion following neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer is associated with poor clinical outcome

Sandra van Wilpe, Shabaz Sultan, Mark A. J. Gorris, Diederik M. Somford, Heidi V. N. Kusters-Vandevelde, Rutger H. T. Koornstra, Winald R. Gerritsen, Michiel Simons, Antoine G. van der Heijden, I. Jolanda M. de Vries, Niven Mehra

Open Access Original Article

Cancer-targeted photoimmunotherapy induces antitumor immunity and can be augmented by anti-PD-1 therapy for durable anticancer responses in an immunologically active murine tumor model

Michelle A. Hsu, Stephanie M. Okamura, C. Daniel De Magalhaes Filho, Daniele M. Bergeron, Ahiram Rodriguez, Melissa West, Deepak Yadav, Roger Heim, Jerry J. Fong, Miguel Garcia-Guzman

Gastric Cancer Original Article

The tissue-resident marker CD103 on peripheral blood T cells predicts responses to anti-PD-1 therapy in gastric cancer

Yohei Nose, Takuro Saito, Kei Yamamoto, Kotaro Yamashita, Koji Tanaka, Kazuyoshi Yamamoto, Tomoki Makino, Tsuyoshi Takahashi, Atsunari Kawashima, Miya Haruna, Michinari Hirata, Azumi Ueyama, Kota Iwahori, Taroh Satoh, Yukinori Kurokawa, Hidetoshi Eguchi, Yuichiro Doki, Hisashi Wada

Ovarian Cancer Original Article

Long-term outcomes of patients with recurrent ovarian cancer treated with a polyvalent vaccine with bevacizumab combination

Ryan M. Kahn, Govind Ragupathi, Qin C. Zhou, Alexia Iasonos, Sara Kravetz, Martee L. Hensley, Jason A. Konner, Vicky Makker, William P. Tew, Carol Aghajanian, Paul J. Sabbatini, Roisin E. O’Cearbhaill

Open Access Radiotherapy Original Article

TIGIT blockade enhances tumor response to radiotherapy via a CD103 + dendritic cell-dependent mechanism

Kaikai Zhao, Liyang Jiang, Youjiao Si, Shujie Zhou, Zhaoqin Huang, Xiangjiao Meng

Lymphoma Original Article

Efficacy and safety of chimeric antigen receptor T-cells treatment in central nervous system lymphoma: a PRISMA-compliant single-arm meta-analysis

Liwei Lv, Yuchen Wu, Han Shi, Xuefei Sun, Zixin Deng, Hongjia Huo, Ruonan Li, Yuanbo Liu

Metastasis Original Article

Dual CAR-T cells to treat cancers co-expressing NKG2D and PD1 ligands in xenograft models of peritoneal metastasis

Guangyi Jiang, Yu Yang Ng, Johan C. K. Tay, Zhicheng Du, Lin Xiao, Shu Wang, Jianqing Zhu

Prostate Cancer Original Article

Identification of novel serological autoantibodies in Chinese prostate cancer patients using high-throughput protein arrays

Ning Lou, Cuiling Zheng, Yanrong Wang, Caixia Liang, Qiaoyun Tan, Rongrong Luo, Lei Zhang, Tongji Xie, Yuankai Shi, Xiaohong Han

Open Access Myelodysplastic Syndrome Research Report

Hematologic malignancies following immune checkpoint inhibition for solid tumors

Mick J. M. van Eijs, Lotte E. van der Wagen, Rogier Mous, Roos J. Leguit, Lisette van de Corput, Anne S. R. van Lindert, Britt B. M. Suelmann, Anna M. Kamphuis, Stefan Nierkens, Karijn P. M. Suijkerbuijk

Research Report

Host B cells escape CAR-T immunotherapy by reversible downregulation of CD19

Sara Fioretti, Courtney A. Matson, Kenneth M. Rosenberg, Nevil J. Singh

Open Access Acute Myeloid Leukemia Research Report

High salt diet does not impact the development of acute myeloid leukemia in mice

Mathangi Janakiraman, Natallia Salei, Gurumoorthy Krishnamoorthy

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine